Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02944396
Title Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie

lung non-small cell carcinoma


Carboplatin + Paclitaxel + Pemetrexed Disodium + Veliparib

Carboplatin + Nivolumab + Paclitaxel + Pemetrexed Disodium + Veliparib

Age Groups: adult | senior
Covered Countries USA

No variant requirements are available.